Sciclone Pharma (SCLN) Reports Q3 EPS of $0.26

Sciclone Pharma (NASDAQ: SCLN) reported Q3 EPS of $0.2, versus $0.17 reported last year. Revenue for the quarter came in at $42.9 million, versus $34.3 million reported last year.

For earnings history and earnings-related data on Sciclone Pharma (SCLN) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• Visa (V) Tops Q2 EPS by 7c, offers guidance
• KKR Real Estate Finance Trust (KREF) Tops Q1 EPS by 4c